 |
|
|
|
|
|||||
|
|||||||||
|
|||||||||
 |
 |
||||||||
|
|
|||||||||
 |
|||||||||
 |
|||||||||
David J. Corwin, M.D. |
Undergraduate Education: University of Michigan (Ann Arbor, MI) Medical School: University of Michigan (Ann Arbor, MI) Residency(s): Anatomic Pathology (University of Washington, Seattle, WA) Laboratory Medicine (University of Washington, Seattle, WA) Board Certification(s): Anatomic Pathology Clinical Pathology Hematopathology Additional Sub-Specialty Expertise: Clinical Chemistry (tumor markers, endocrine testing, serologic testing, and prenatal testing) Direct Immunofluorescence Flow Cytometry Hematopathology Laboratory Administration |
Commentary/Medical Interests:
Dr. Corwin is the President of CellNetix Pathology & Laboratories, and Director of Laboratories at Swedish Medical Center in Seattle, WA. Dr. Corwin is consistently named by his peers as one of Seattle's top pathologists, appearing year after year in the "Best Doctors" issues of regional magazines such as Seattle and Seattle Metropolitan. He is currently a Clinical Associate Professor at the University of Washington School of Medicine, serves on the Immunology Device Advisory Board of the Food and Drug Administration (FDA), and is a member of the Consultant Panel at The Center for Health Dispute Resolution. Dr. Corwin has also served as Chairman of the Cell Marker's Committee for the College of American Pathologists (CAP). |
|||||||
|
|||||||||
|
|||||||||
